Bringing breakthrough regenerative medicine therapies to Minnesotans
Regenerative Medicine Minnesota funds projects to develop innovative regenerative therapies and technologies, aiming to advance scientific breakthroughs and patient care across Minnesota.
Funder: Regenerative Medicine Minnesota
Due Dates: October 22, 2026: Application submission deadline
Funding Amounts: Up to $400,000 total ($200,000/year) for up to 2 years; larger requests require strong justification.
Summary: Supports Minnesota-based projects advancing regenerative medicine therapies, technologies, and collaborations to improve patient access and strengthen the state's leadership.
Description
Regenerative Medicine Minnesota (RMM) seeks proposals that accelerate the development and delivery of innovative regenerative medicine therapies. This opportunity is designed to fund projects that advance novel therapies and products, develop enabling technologies and platforms, build infrastructure, and foster collaborations across sectors. The goal is to strengthen Minnesota’s leadership in regenerative medicine and generate significant health and economic benefits for Minnesotans. Areas of particular interest include platform-based approaches for rare diseases, device-enabled innovations, and strategies to improve immune compatibility and therapeutic durability.
